Research Topic: biocatalysis

An Overview of Microorganisms Immobilized in a Gel Structure for the Production of Precursors, Antibiotics, and Valuable Products

mycolabadmin

Scientists have developed methods to trap bacteria and fungi inside gel structures, similar to tiny capsules. These immobilized microorganisms can produce antibiotics and other useful medicines more efficiently and continuously than free-floating cells. The gel structures protect the cells, allow them to be reused multiple times, and reduce production costs, making medicine manufacturing faster and cheaper.

Read More »

Enhancing the Substrate Adaptability of Laccase through Ancestral Sequence Reconstruction for Applications in Mycotoxin Detoxification

mycolabadmin

Researchers used evolutionary analysis to redesign a fungal enzyme called laccase to better detoxify harmful mold toxins found in grains. The new engineered enzyme (LacANC278) can break down both aflatoxin and zearalenone toxins much more effectively than the original enzyme, and converts them into less harmful substances. This enzyme works without expensive helper chemicals and works well at room temperature, making it practical for treating contaminated corn and other grains.

Read More »

A Review of Synthetic Access to Therapeutic Compounds Extracted from Psilocybe

mycolabadmin

Scientists have discovered that magic mushrooms contain compounds called psilocybin and psilocin that show promise in treating depression and other psychiatric conditions. However, extracting enough of these compounds from mushrooms is difficult, so chemists have developed multiple ways to synthesize them in laboratories. This review examines different chemical and biological methods for producing these therapeutic compounds, from traditional synthesis techniques to modern approaches using special catalysts and enzymes, making these medicines more accessible for clinical research.

Read More »

Scalable Hybrid Synthetic/Biocatalytic Route to Psilocybin

mycolabadmin

Researchers developed a new method to manufacture psilocybin, a promising therapeutic compound from magic mushrooms being tested to treat depression. Instead of using toxic chemicals, they replaced a difficult chemical step with an enzyme from the mushroom itself called PsiK. This approach produced gram amounts of pure psilocybin efficiently and could eventually lower costs for future medical use.

Read More »

Research Progress on Nutritional Components, Functional Active Components, and Pharmacological Properties of Floccularia luteovirens

mycolabadmin

Floccularia luteovirens is a special mushroom from the Qinghai-Tibet Plateau that has been used in traditional Tibetan medicine for centuries. It is extremely nutritious, containing as much protein as meat and numerous beneficial compounds. Scientific research shows it can help fight disease, boost immunity, and even preserve food naturally, making it promising for development as a health supplement and functional food.

Read More »

Bioinformatics-aided identification, characterization and applications of mushroom linalool synthases

mycolabadmin

Scientists discovered a special enzyme from mushrooms that efficiently produces linalool, a fragrance ingredient found in most perfumes and cosmetics. This fungal enzyme is much more efficient and selective than similar enzymes from plants or bacteria, making it ideal for mass-producing natural linalool through fermentation. The study used advanced computer analysis to identify the enzyme and revealed specific parts of the enzyme responsible for its excellent performance, which could help design even better enzymes in the future.

Read More »
Scroll to Top